Terlecki-Zaniewicz L, Lmmermann I, Latreille J, et al
Recalls & Warnings May 01, 2024 FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints On April 17, 2024, the FDA warned consumers not to purchase or use Ossos-Sans, a supplement promoted to treat osteoarthritis, osteoporosis, and other conditions, because it contains undeclared drugs, including diclofenac and methocarbamol
Lancet 335: 669 [DOI] [PubMed] [Google Scholar] 31
Real Peptides manufactures all peptides as lyophilized powders requiring reconstitution with bacteriostatic water to ensure maximum stability during shipping and storage
Individuals with gastrointestinal disorders like celiac disease, Crohn's disease, or surgical alterations in the gastrointestinal tract may also experience impaired B12 absorption